Advancedsolutions
advancedsolutions.com
Actively hiring
Logistics
Regenerative Medicine
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$88.5M
4 rounds on record
Latest round
$1000k
Venture round · Jan 2022 · 4 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
57 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026
Formerly Advanced Solutions Life Sciences (biobots.io)
Jan 21, 2022
Board appointment Doug Schoenberg, Director · SEC Form D
Jan 7, 2022
Raised a round Venture round $1000k · SEC Form D
Oct 1, 2020
Board appointment Donald Hawks III, Director · SEC Form D
Sep 16, 2020
Raised a round Venture round $35M · SEC Form D
2020
Founded
May 24, 2017
New executive Don Robertson, Executive Officer, Director · SEC Form D
May 12, 2017
Raised a round Venture round $26M · SEC Form D
Jul 6, 2016
Raised a round Venture round $26.5M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2022 | $1000k | — | SEC Form D |
| Venture round | Sep 2020 | $35M | — | SEC Form D |
| Venture round | May 2017 | $26M | — | SEC Form D |
| Venture round | Jul 2016 | $26.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Advanced Solutions International, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert AlvesExecutive Officer, DirectorSEC Form D
Jocelyn DyerExecutive OfficerSEC Form D
Don RobertsonExecutive Officer, DirectorSEC Form D
Gary KinmanExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine…
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Explore stem cells and regenerative medicine. Learn about mCELL™, published research, and resources for patients and physicians.
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
Brinter is 3D bioprinting regenerative implants for the $1T tissue repair market. We develop bio-inductive, fully resorbable implants…
People
Robert Alves
Executive Officer, Director
Jocelyn Dyer
Executive Officer
Don Robertson
Executive Officer, Director
Gary Kinman
Executive Officer
Dan Testa
Director
Adam Fuller
Director
Daniel Kim
Director
Donald Hawks III
Director
Michael LaConti
Director
Doug Schoenberg
Director
Richard Davis
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Louisville
United States
HQ
1901 Nelson Miller Parkway, Louisville, KY 40223
Alexandria
United States
HQ
Manchester
United States
Engineering / R&D
Research Laboratory
500 N Commercial Street, Manchester, NH 03101